comparemela.com

Latest Breaking News On - Larkspur health acquisition - Page 1 : comparemela.com

ZyVersa Therapeutics Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results

Key Highlights: Closed business combination with Larkspur Health Acquisition Corp. in December 2022 and began trading on Nasdaq Global Market under the ticker symbol “ZVSA”Planning. | April 3, 2023

United statesDave schemeliaRobertw keaneCasey mcdonaldStephenc gloverRivero vaccariUniversity of miami miller school medicineLarkspur health acquisition corpZyversa therapeutics incDrug administrationTranslational researchTiberend strategic advisors incSecurities exchangeMichaelj fox foundationKey highlightsLarkspur health acquisition

ZYVERSA THERAPEUTICS, INC : Change in Directors or Principal Officers (form 8-K)

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 5, 2023, the Board of Directors. | January 6, 2023

New jerseyUnited statesUnited kingdomMacalester collegeBio pharmaKatrin rupallaGregory freitagStephen gloverJames sapirsteinAmbrx biopharma incCompensation committeeLectec corporationBiotechnology corporationResearch development quality at lundbeckAxogen incPfizer inc

ZyVersa Therapeutics Inc and Larkspur Health Acquisition Corp Close Business Combination; ZyVersa Expected to Begin Trading on Nasdaq December 13, 2022 (Ticker ZVSA )

/PRNewswire/ ZyVersa Therapeutics, Inc. ("ZyVersa"), a clinical stage specialty biopharmaceutical company leveraging advanced proprietary technologies to.

Stephenc gloverPhelps phillipsDanielj oconnorNoble capital markets incPurpose acquisition companyPrnewswire zyversa therapeutics incAlston birdZyversa therapeutics incA gp alliance global partnersSecurities exchangeLowenstein sandlerLarkspur health acquisition corpVersa therapeuticsLarkspur health acquisitionZyversa therapeuticsChief executive officer

Health Care Up as Horizon Rises on Deal — Health Care Roundup

Health Care Up as Horizon Rises on Deal — Health Care Roundup
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Eli lillyRob curranLarkspur health acquisitionDow jones company incClovis oncologyDow jones

Health Care Up as Horizon Rises on Deal -- Health Care Roundup

Health-care companies rose amid deal activity. Horizon Therapeutics rallied after the biotech concern, which specializes in autoimmune and inflammatory-disease drugs, agreed to a $27.8 billion.

Eli lillyRob curranLarkspur health acquisitionClovis oncologyDow jones

vimarsana © 2020. All Rights Reserved.